News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Flagship Ventures Fund IV General Partner LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 07/13/2023 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Bought 1,082,251 shares
@ $2.31, valued at
$2.5M
Bought 1,082,251 shares
@ $2.31, valued at
$2.5M
Bought 3,246,753 shares
@ $2.31, valued at
$7.5M
|
|
| 02/14/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 11/14/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 10/17/2022 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Bought 2,743,902 shares
@ $1.64, valued at
$4.5M
Bought 2,757,333 shares
@ $1.64, valued at
$4.5M
Bought 914,634 shares
@ $1.64, valued at
$1.5M
Bought 919,111 shares
@ $1.64, valued at
$1.5M
Bought 3,048,780 shares
@ $1.64, valued at
$5M
|
|
| 08/15/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 06/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 03/18/2022 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Bought 3,791,623 shares
@ $1.91, valued at
$7.2M
Bought 947,905 shares
@ $1.91, valued at
$1.8M
Bought 1,579,843 shares
@ $1.91, valued at
$3M
|
|
| 02/14/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Flagship Ventures Fund IV General Partner LLC reports a 42.9% stake in Rubius Therapeutics, Inc. |
| 11/15/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/16/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/17/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
SC 13G/A
| Flagship Ventures Fund IV General Partner LLC reports a 47.4% stake in Rubius Therapeutics, Inc. |
| 02/16/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/25/2020 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Disposed of 3,587,820 shares
@ $0
Disposed of 642,180 shares
@ $0
Disposed of 966,234 shares
@ $0
Disposed of 1,186,310 shares
@ $0
Disposed of 1,481,481 shares
@ $0
Disposed of 43,154 shares
@ $0 |
|
| 11/16/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/13/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2020 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Kaleido Biosciences, Inc.|
Txns:
| Bought 666,667 shares
@ $7.5, valued at
$5M
Bought 666,667 shares
@ $7.5, valued at
$5M
Bought 666,666 shares
@ $7.5, valued at
$5M
|
|
| 05/26/2020 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Moderna, Inc.|
Txns:
| Sold 223,314 shares
@ $65.7661, valued at
$14.7M
Sold 121,771 shares
@ $67.1504, valued at
$8.2M
Sold 39,082 shares
@ $68.8144, valued at
$2.7M
Sold 20,492 shares
@ $70.4564, valued at
$1.4M
Sold 13,408 shares
@ $71.5141, valued at
$958.9k
Sold 1,933 shares
@ $72.4351, valued at
$140k
Sold 42,540 shares
@ $65.7661, valued at
$2.8M
Sold 23,199 shares
@ $67.1504, valued at
$1.6M
Sold 7,443 shares
@ $68.8143, valued at
$512.2k
Sold 3,900 shares
@ $70.4564, valued at
$274.8k
Sold 2,551 shares
@ $71.5144, valued at
$182.4k
|
|
| 05/20/2020 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Bought 1,520,000 shares
@ $4.75, valued at
$7.2M
Bought 380,000 shares
@ $4.75, valued at
$1.8M
Bought 1,900,000 shares
@ $4.75, valued at
$9M
|
|
| 05/14/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/13/2020 |
SC 13G/A
| Flagship Ventures Fund IV General Partner LLC reports a 15.3% stake in Moderna, Inc. |
| 12/11/2019 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Moderna, Inc.|
Txns:
| Disposed of 6,292,342 shares
@ $0
Disposed of 1,207,658 shares
@ $0
Disposed of 1,735,720 shares
@ $0
Sold 144,423 shares
@ $18.9942, valued at
$2.7M
Sold 27,714 shares
@ $18.9943, valued at
$526.4k
Sold 21,325 shares
@ $18.9586, valued at
$404.3k
Sold 4,092 shares
@ $18.9586, valued at
$77.6k
Sold 199,935 shares
@ $18.6548, valued at
$3.7M
Sold 38,366 shares
@ $18.6548, valued at
$715.7k
|
|
|
|
|